These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 32574790)

  • 1. Clonal outbreak caused by VIM-4-producing Proteus mirabilis in a Greek tertiary-care hospital.
    Protonotariou E; Poulou A; Politi L; Meletis G; Chatzopoulou F; Malousi A; Metallidis S; Tsakris A; Skoura L
    Int J Antimicrob Agents; 2020 Aug; 56(2):106060. PubMed ID: 32574790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmission in the community of clonal Proteus mirabilis carrying VIM-1 metallo-beta-lactamase.
    Tsakris A; Ikonomidis A; Poulou A; Spanakis N; Pournaras S; Markou F
    J Antimicrob Chemother; 2007 Jul; 60(1):136-9. PubMed ID: 17491004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospital outbreak due to a Klebsiella pneumoniae ST147 clonal strain co-producing KPC-2 and VIM-1 carbapenemases in a tertiary teaching hospital in Northern Greece.
    Protonotariou E; Poulou A; Politi L; Sgouropoulos I; Metallidis S; Kachrimanidou M; Pournaras S; Tsakris A; Skoura L
    Int J Antimicrob Agents; 2018 Sep; 52(3):331-337. PubMed ID: 29654892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibilities of Proteus mirabilis: a longitudinal nationwide study from the Taiwan surveillance of antimicrobial resistance (TSAR) program.
    Wang JT; Chen PC; Chang SC; Shiau YR; Wang HY; Lai JF; Huang IW; Tan MC; Lauderdale TL;
    BMC Infect Dis; 2014 Sep; 14():486. PubMed ID: 25192738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Characterization of β-Lactam Resistance and Antimicrobial Susceptibility to Possible Therapeutic Options of AmpC-Producing Multidrug-Resistant
    Rubic Z; Soprek S; Jelic M; Novak A; Goic-Barisic I; Radic M; Tambic-Andrasevic A; Tonkic M
    Microb Drug Resist; 2021 Feb; 27(2):162-169. PubMed ID: 32429775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nosocomial outbreak by Proteus mirabilis producing extended-spectrum beta-lactamase VEB-1 in a Korean university hospital.
    Kim JY; Park YJ; Kim SI; Kang MW; Lee SO; Lee KY
    J Antimicrob Chemother; 2004 Dec; 54(6):1144-7. PubMed ID: 15546971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First report of bla
    Leulmi Z; Kandouli C; Mihoubi I; Benlabed K; Lezzar A; Rolain JM
    J Glob Antimicrob Resist; 2019 Mar; 16():125-129. PubMed ID: 30217548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissemination of a Multidrug-Resistant VIM-1- and CMY-99-Producing Proteus mirabilis Clone in Bulgaria.
    Markovska R; Schneider I; Keuleyan E; Ivanova D; Lesseva M; Stoeva T; Sredkova M; Bauernfeind A; Mitov I
    Microb Drug Resist; 2017 Apr; 23(3):345-350. PubMed ID: 27341161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular drivers of emerging multidrug resistance in Proteus mirabilis clinical isolates from Algeria.
    Boudjemaa H; Allem R; Fonkou MDM; Zouagui S; Khennouchi NCEH; Kerkoud M
    J Glob Antimicrob Resist; 2019 Sep; 18():249-256. PubMed ID: 30797091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of Proteus mirabilis carrying the bla metallo-beta-lactamase gene.
    Vourli S; Tsorlini H; Katsifa H; Polemis M; Tzouvelekis LS; Kontodimou A; Vatopoulos AC
    Clin Microbiol Infect; 2006 Jul; 12(7):691-4. PubMed ID: 16774572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of multidrug-resistant Proteus mirabilis in a long-term care facility in Croatia.
    Bedenić B; Firis N; Elveđi-Gašparović V; Krilanović M; Matanović K; Štimac I; Luxner J; Vraneš J; Meštrović T; Zarfel G; Grisold A
    Wien Klin Wochenschr; 2016 Jun; 128(11-12):404-13. PubMed ID: 27220339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type beta-lactamase: epidemiology and clinical management.
    Luzzaro F; Brigante G; D'Andrea MM; Pini B; Giani T; Mantengoli E; Rossolini GM; Toniolo A
    Int J Antimicrob Agents; 2009 Apr; 33(4):328-33. PubMed ID: 19095415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Characteristic of resistance to beta-lactam antibiotics of nosocomial strains of Proteus mirabilis].
    Ivanov DV
    Zh Mikrobiol Epidemiol Immunobiol; 2008; (6):75-8. PubMed ID: 19189465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapidly spreading CTX-M-type beta-lactamase-producing Proteus mirabilis in Japan.
    Kanayama A; Iyoda T; Matsuzaki K; Saika T; Ikeda F; Ishii Y; Yamaguchi K; Kobayashi I
    Int J Antimicrob Agents; 2010 Oct; 36(4):340-2. PubMed ID: 20609568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First outbreak of VIM-2 metallo-β-lactamase-producing Pseudomonas aeruginosa in The Netherlands: microbiology, epidemiology and clinical outcomes.
    Van der Bij AK; Van Mansfeld R; Peirano G; Goessens WH; Severin JA; Pitout JD; Willems R; Van Westreenen M
    Int J Antimicrob Agents; 2011 Jun; 37(6):513-8. PubMed ID: 21497065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clusters of imipenem-resistant Acinetobacter baumannii clones producing different carbapenemases in an intensive care unit.
    Tsakris A; Ikonomidis A; Poulou A; Spanakis N; Vrizas D; Diomidous M; Pournaras S; Markou F
    Clin Microbiol Infect; 2008 Jun; 14(6):588-94. PubMed ID: 18397334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outbreak caused by Proteus mirabilis isolates producing weakly expressed TEM-derived extended-spectrum β-lactamase in spinal cord injury patients with recurrent bacteriuria.
    Cremet L; Bemer P; Rome J; Juvin ME; Navas D; Bourigault C; Guillouzouic A; Caroff N; Lepelletier D; Asseray N; Perrouin-Verbe B; Corvec S
    Scand J Infect Dis; 2011 Dec; 43(11-12):957-61. PubMed ID: 21888562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties of multidrug-resistant, ESBL-producing Proteus mirabilis isolates and possible role of beta-lactam/beta-lactamase inhibitor combinations.
    Luzzaro F; Perilli M; Amicosante G; Lombardi G; Belloni R; Zollo A; Bianchi C; Toniolo A
    Int J Antimicrob Agents; 2001 Feb; 17(2):131-5. PubMed ID: 11165117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece.
    Pournaras S; Protonotariou E; Voulgari E; Kristo I; Dimitroulia E; Vitti D; Tsalidou M; Maniatis AN; Tsakris A; Sofianou D
    J Antimicrob Chemother; 2009 Aug; 64(2):348-52. PubMed ID: 19525514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of Proteus mirabilis harboring blaKPC-2 and qnrD in a Chinese Hospital.
    Hu YY; Cai JC; Zhang R; Zhou HW; Sun Q; Chen GX
    Antimicrob Agents Chemother; 2012 May; 56(5):2278-82. PubMed ID: 22354308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.